Clinical Trials on Relapsed CLL

Total 440101 results

BioDelivery Sciences International

Completed

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Opioid Dependence

United States
Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens

Opioid-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1

Heroin Dependence

United States
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
Butler Hospital

Completed

Distress Tolerance and Buprenorphine (TRUST)

Opioid Dependence

United States
MacDonald, Kai, M.D.

Unknown

Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

Opiate Dependence

United States
State University of New York at Buffalo

Withdrawn

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Opiate Addiction

United States
Hurd,Yasmin, Ph.D.

Completed

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

Opiate Addiction

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Completed

Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts

Heroin Dependence

Russian Federation
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Stress and Other Factors on Opiate Drug Choice. (DSS)

Opioid-Related Disorders | Heroin Dependence

United States
University of Oslo
The Research Council of Norway

Completed

Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services

Opiate Addiction

Norway
National Cheng-Kung University Hospital

Unknown

Combined Therapy of Methadone and Dextromethrophan (DM)

Opioid Abuse

Taiwan
Assaf-Harofeh Medical Center

Unknown

Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.

Opioid Addiction

Israel
California Pacific Medical Center Research Institute

Completed

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects (AIKO-150)

Opiate Addiction

United States
US Department of Veterans Affairs
National Institute on Drug Abuse (NIDA); Reckitt and Colman

Completed

Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

Opiate Dependence

United States
Vilnius University

Completed

Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia

Opiate Dependence

Lithuania
Johns Hopkins University

Completed

Opioid Maintenance Medications Comparison Study

Opioid Dependence

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use

Opioid Use Disorder | Alcohol Use Disorder

United States
Shanghai Jiao Tong University School of Medicine

Completed

Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

Relapse Rate After Allo-HSCT

China
Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Opioid Use Disorder | Buprenorphine Dependence | Methadone Dependence

United States
Indivior Inc.

Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder | Opioid-related Disorders

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
Kati Järvelä

Completed

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

Postoperative Pain | Opioid Related Disorders

Finland
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Medications Development for Drug Abuse Disorders

Opioid Dependence | Opioid Related Disorders | Opioid Addiction

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Recruiting

Substance Abuse Pre-Treatment Screening Study

Alcohol Dependence | Substance Abuse | Cocaine Dependence | Opiate Dependence | Cocaine Abuse

United States
Helen Keller International
Eleanor Crook Foundation

Not yet recruiting

Maternal Adherence to MMS in Nepal (NAMASTE MMS)

Pregnancy Related | Supplementation | Postnatal Related
Dana-Farber Cancer Institute

Completed

Cabozantinib With Topotecan-Cyclophosphamide

Refractory Ewing Sarcoma | Refractory Osteosarcoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma

United States
Masonic Cancer Center, University of Minnesota

Completed

HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma

Refractory B-Lineage Leukemia | Relapsed B-Lineage Leukemia | Refractory B-Lineage Lymphoma | Relapsed B-Lineage Lymphoma

United States
Kite, A Gilead Company

Recruiting

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)

Relapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell Leukemia

United States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
Assistance Publique - Hôpitaux de Paris

Completed

Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients (COM-ON)

Opioid-related Disorders | Opiate Dependence | Opiate Addiction | Opiate Abuse

France
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals

Opioid-Related Disorders | Heroin Dependence | Cocaine Abuse or Dependence

United States
Jerry Cochran
Castleview Hospital

Recruiting

Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment (BINDeR-TX)

Opioid Abuse

United States
Singapore General Hospital

Recruiting

A Multi-centre Survey on Tramadol Abuse in Singapore

Opioid Abuse

Singapore
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence (THED)

Heroin Dependence

China
Indivior Inc.
National Institute on Drug Abuse (NIDA)

Completed

INDV-2000 First in Human

Opioid Dependence

United States
University of Southern California
Northwestern University; National Institute on Aging (NIA); AltaMed Health Services...

Completed

AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm (AESOPS-2)

Opioid Abuse

United States
Emory University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Community Trial in the Cherokee Nation

Opioid Abuse

United States
San Francisco Department of Public Health

Completed

Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients (REBOOT)

Opioid-Related Disorders | Drug Overdose

United States
University of Wisconsin, Madison

Completed

Dane County Drug Court Study for Addicted Offenders

Opioid Dependence

United States
Yale University
United States Department of Defense

Completed

Buprenorphine Treatment for Opioid Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
Alkermes, Inc.

Terminated

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Heroin Dependence

United States
University Hospital, Toulouse

Completed

On-site Evaluation of Substances Consumption on Opiate Maintenance (ESUB-MG)

Opiate Addiction

France
University Hospital, Clermont-Ferrand
UFR de Pharmacie (Clermont-Ferrand)

Completed

Assessment of the Satisfaction of Patient Undergoing Opioid Replacement Therapy Toward Their Management in Community Pharmacy (SATISFY)

Opioid-Related Disorders

France
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
University of Pennsylvania
Patient-Centered Outcomes Research Institute

Completed

Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (OAPXRNTX)

Opiate Dependence

United States
NYU Langone Health

Withdrawn

Needle-X: Usability Testing of a Smartphone Application

Opioid Dependence

United States
University of Alabama at Birmingham

Withdrawn

Comparison of Three Opioid Detoxification Treatment Regimens

Opioid-Related Disorders | Opioid Withdrawal

United States

Clinical Trials on Relapsed CLL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations